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ABSTRACT
Recently, several clinical trials have been published to discuss the possibility of probiotic supplementation, es-
pecially some products of lactic acid bacteria such as Lactobacillus and Bifidobacterium strains, in prevention
and treatment of allergic disorders. However, the results of some investigations were inconsistent with each
other. The contradictory effect of probiotics among different individuals might suggest differences in genetic or
environmental factors, or both. It is conceivably beneficial to use inbred mice as experimental models to ex-
plore whether the effect of probiotics on limiting allergy is under the influence of genetic factors. In this review,
firstly, we summarized recent publications regarding the effects of lysed Enterococcus faecalis FK-23 (LFK),
which is a preparation of a probiotic lactic acid bacterium strain, on suppressing allergic responses in BALBc
mice. And then, we presented our latest data focused on the effects of LFK on suppressing active cutaneous
anaphylaxis and local accumulation of eosinophils in four inbred mouse models by using the BALBc, C57BL
6, C3HHeN and C3HHeJ strains. The finding of our experimental study suggests that the effect of LFK on
combating allergic inflammatory reactions might be affect by individuals’ hereditary background.
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INTRODUCTION
There have been many studies showing that oral ad-
ministration of lactic acid bacteria including Lactoba-
cillus, Bifidobacterium and Enterococcus has abundant
physiological activities, such as the treatment of rota-
virus gastroenteritis1-3 and acute infectious diarrhea,4
improvement of Crohn’s disease,5,6 protection against
influenza virus7,8 and Helicobacter pylori infection,9,10
inhibitory effect on tumor cells , 11-16 antihyperten-
sion 17,18 and antihyperlipemia . 19,20 Live bacteria
which show health effects on hosts are referred to as
probiotics.21
Research on the anti-allergy effects of probiotics
have produced a marked advance in the application of
probiotic supplements. Numerous animal model stud-
ies , 22-26 epidemiology surveys and clinical tests 27-32
have been published to discuss the possibility of pro-
biotics in suppressing allergic responses. However,
the effect of probiotics on controlling allergy seems
to be still inconsistent in clinical applications. Inter-
estingly, there are some patients whose symptoms
deteriorate following the use of probiotics.29 This con-
tradictory effect of probiotics among different indi-
viduals might suggest differences in environmental
factors. At the same time, many epidemiological stud-
ies including familial accumulation also suggest the
presence of hereditary background in allergic dis-
eases. Therefore, allergic disorders seem to be re-
lated to both genetic and environmental factors.
Although various candidate genes for Japanese ce-
dar pollinosis, which is one of the most common al-
lergic diseases in Japan, have been recruited for stud-
ies using the candidate gene approach,33,34 the role of
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WeisselaLactobacilus
OenococcusPediococcus
AtopobiumTetragenococcus
StreptococcusCarnobacterium
EnterococcusVagococcus
LactococcusLeuconostoc
Table 1 12 genus of lactic acid bacteria
gene-environment interaction cannot be excluded in
the discussion. However, it is difficult to investigate
the relationship between genetic factors and allergic
diseases in the same environment in humans. It is
conceivably beneficial, therefore, to use inbred mice
as experimental subjects, whose genetic and environ-
mental factors can be possibly set at the same level.
In the present study, we used the most useful mice
strains, BALBc, C57BL6 and C3HHe, for allergic
models,35,36 and made a comparative study of the ef-
fectiveness of probiotic supplements on suppressing
allergic responses including Japanese cedar pollen in-
duced active cutaneous anaphylaxis (ACA) and local
accumulation of eosinophils . Furthermore , we dis-
cussed the relationship between probiotics and toll-
like receptor (TLR) 4 by using C3HHeJ, as a resis-
tance responder against lipopolysaccharaide (LPS )
due to a point mutation on TLR4.37
LACTIC ACID BACTERIA AND PROBIOTICS
Lactic acid bacteria and food had been known to be
beneficial for the human body through experience
even before Mechinikov advocated friendly bacte-
riain 1908.Lactic acid bacteriain a broad sense is
a general designation for microorganisms that pro-
duce lactic acid . The term probiotics includes not
only lactic acid fermentation bacteria but also even
Escherichia coli and yeasts. It has become possible to
discuss phyletic lines by comparing base sequences
of DNA and RNA in recent years. Lactic acid bacteria
are classified into 12 genera (Table 1). Bifidobacte-
rium is not classified as a lactic acid bacterium by this
definition because it does not metabolize 50% of car-
bohydrates into lactic acid. However, taking into ac-
count its image generally held in the past and its
functionality, we might probably pose no problem to
classify it as a lactic acid bacterium.
Lactic acid bacteria considered beneficial for the
human body have been called probiotics and known
to the general public from recent years . In 1987,
Fuller38 defined probiotics as live microorganisms
that show health effects on hosts by altering the bal-
ance of intestinal bacteriaFurthermore , in 1998
Salminen et al.21 definedprobiotics are food which
contain live bacteria which are beneficial to health
By this definition, they argued that probiotics include
not only bacteria such as lactic acid bacteria, Bacillus,
and Escherichia coli themselves, but also fermented
food such as yoghurt, pickles, and cheese. We are in
agreement with the opinion of some other authors
that probiotic supplements should include not only
live bacteria but also dead bacteria, treated bacteria,
and components of bacteria.
LFK is a product of lysozyme and heat-treated En-
terococcus faecalis FK-23. Enterococcus faecalis, one of
many lactic acid bacteria abundant in the human in-
testinal tract, is not used as a live bacterium but it is
lysed with a lysozyme and then heated at 110 to
prepare a branded product of lactic acid bacteria ,
which is used as a probiotic supplement in Japan. Pre-
vious experiments have confirmed that LFK was
more effective than live or heat-sterilized bacteria of
this strain in suppressing allergic reactions not only
in animal experiments , 25,26 but also in clinical tri-
als.39,40
MOUSE AS EXPERIMENTAL ANIMAL
Experiments with various animals have a long his-
tory ; William Harvey of the UK dissected various
animals such as frogs, snakes, dogs, pigs, and others
in the 17th century during the Renaissance era and
suggested that the heart and blood circulation were
related. This is considered the beginning of animal
experimentsMice and rats, which were considered
pet animals before, were given attention for research
purposes and converted to experimental animals in
the 20th century. In the latter half of the 20th century,
various experimental animals ranging from fish and
amphibians to such mammals as mice, rats, mongo-
lian gerbils, guinea pigs, ferrets, rabbits, cats, and
dogs and even simians have become available. Their
rearing environments and feeds have become con-
trollable. Good laboratory practice (GLP) for proper
animal tests is now compulsory to ensure the reliabil-
ity of data
Mice are used most often among the various ex-
perimental animals . Mice have more merits than
other experimental animals : they do not grow larger
than 50 grams and are small at maturity ; they have a
high reproduction rate ; a great number of their in-
bred lines are registered internationally and do not
easily suffer inbreeding devolution ; and knock-out
mice can be produced. Therefore, efforts have been
made for controlling their genes for a long time (Ta-
ble 2). At present, mice of inbred strains are the most
useful animals for these studies because of their es-
tablished genetic homogeneity. Inbred strains can be
put on record internationally, while there is inbreed-
ing for over twenty generations. When the coefficient
of inbreeding (F) is over 98.6%, it is stipulated that
the difference in genes among siblings is 0.4%. Within
each inbred strain, all mice have the same character-
istics, including color of hair, temperament, immunity
and physiology. Therefore, they are used as subjects
in various investigations
The following allergy models may be cited :
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Fig. 1 Used mouse strain on alergic models
BALB/c
C57BL/6
C3H/He
Table 2 Color and H-2 marker profile of inbred strains of 
the mouse
H-2 markercolorStrain
H-2dAlbino (AAbbcc)BALB/c
H-2bBlack (aaBBCC)C57BL/6
H-2kAgouti (AABBCC)C3H/He
H-2qDilute broun (aabbCCdd)DBA/1
H-2dDilute brown (aabbCCdd)DBA/2
H-2kAgouti (AABBCC)CBA
H-2kAlbino (aabbcc)MRL
H-2SAlbino (aabbcc)SJL/J
Table 3 Active cutaneous anaphylaxis (ACA) and efect 
of LFK
ACA (absorbance at 620 nm)
p valueLFKcontrol
0.0770.285 ± 0.0700.447 ± 0.080BALB/c
0.4890.604 ± 0.0680.696 ± 0.113C57BL/6
0.9190.357 ± 0.0380.362 ± 0.021C3H/HeN
0.0870.178 ± 0.0310.268 ± 0.032C3H/HeJ
auricular edema model , 41,42 foot edema model , 43,44
ACA model,36 passive cutaneous anaphylaxis (PCA)
model , 45 contact dermatitis by picryl chloride
model, 46 allergic peritonitis model , 37 and antigen-
induced asthma model . 47 In addition , inbred mice
that develop atopic or atopy-like dermatitis and aller-
gic encephalomyelitis have been produced, and new
allergy model lines have been developed using mu-
tant lines and gene-modified mice
Lines used generally as allergy models are BALB
c, C57BL6, and C3HHe besides the mutant lines
and the gene-modified mice (Fig. 1). The BALBc is
known to be Th2-dominant,48 easy to induce oral tol-
erance and possess large organs of the reticuloendo-
thelia system. The C57BL6 strain is known to be
Th1-dominant 48 and show little decline of cellular im-
munopotency with aging. In addition , in the naive
state, BALBc mice have been reported to strongly
express TLR 2, 4, 5 and 6, and C57BL6 mice express
TLR9.49 The C3HHeN strain is characteristically
Th1-dominant and has a high liver cancer incidence.
The C3HHeJ strain, a subline of the C3HHe line,
has some characteristics such as point mutation at
TLR4 and no sensitivity to LPS.37
EFFECT OF LFK ON ACA
This is a model of responses classified as immediate
responses among type I hypersensitivity and a classic
allergy model of an experimental system in which
histamine is considered to be associated with the pro-
duction of allergen-specific IgE and mast cells. The
experimental mice were immunized intramuscularly
with 0.1 mL of Japanese cedar pollen allergen solu-
tion at day 15. Following an intravenous injection of
0.05 mL of 1% Evans Blue, ACA was elicited in the
skin of the belly by subcutaneous injection of 0.05 mL
of allergen solution at day 29. Thirty minutes after al-
lergen challenge, mice were killed and a piece of skin
after shaving was put into 3 mL of mixture solution
containing 0.05% sodium sulfate anhydrous and ace-
tone. After vigorous shaking, the absorbance of ex-
travagated dye was measured colorimetrically at 620
nm.26
In this experimental system, responsiveness was
compared in mice of the BALBc, C57BL6, C3H
HeN, and C3HHeJ strains. As shown in Table 3, re-
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Table 4 Accumulation of eosinophils and efect of LFK
Eosinophils (%)WBC (cels/ml)
p valueLFKcontrolLFKcontrol
0.01613.1 ± 1.719.6 ± 1.91.6 × 1061.6 × 106BALB/c
0.47029.1 ± 1.430.5 ± 1.41.6 × 1061.5 × 106C57BL/6
0.0106.0 ± 0.79.9 ± 1.31.0 × 1061.0 × 106C3H/HeN
0.00412.8 ± 1.118.4 ± 1.41.4 × 1061.7 × 106C3H/HeJ
sponsiveness was more than one and a half times
stronger in the C57BL6 strain than in the BALBc
strain . 50 On the other hand, the C3HHeN strain
showed nearly equivalent responsiveness to the
BALBc strain, and the C3HHeJ strain was half as
responsive as the BALBc strain . While the two
C3HHe strains were somewhat lower in responsive-
ness than the BALB strain, the differences were not
clear. Therefore, it was confirmed that ACA was not
affected by TLR4.
The mouse strains of the above experimental sys-
tem were used for studying the difference of allergy
suppression by LFK. The BALBc, C57BL6, C3H
HeN, and C3HHeJ strains showed 63.8% , 86.8% ,
98.6%, and 66.4%, respectively, to 100% for a control
group in ACA. LFK administration showed a clear
suppressive effect in the BALBc and the C3HHeJ
strains.
EFFECT OF LFK ON ACCUMULATION OF
EOSINOPHILS
This is a model of responses classified as delayed re-
sponses among type I allergy and an experimental
system using allergen-induced peritoneal accumula-
tion of eosinophils as an indicator. The experimental
mice were sensitized with Japanese cedar pollen al-
lergen solution ; 0.1 mL of this dilution was injected
subcutaneously on day 0 and 1, and 0.2 mL was in-
jected subcutaneously on day 6, 8 and 14. The mice
were challenged on day 20 by the intraperitoneal in-
jection of 0.2 mL of the dilution of allergen solution.
Peritoneal cells were harvested 24 hours after chal-
lenge with 4 mL of phosphate-buffered saline contain-
ing 1.0% fetal calf serum and 5 Uml heparin. An ap-
propriate phosphate-buffered saline dilution of the in-
fusion was added to Turks solution , and the total
number of blood cells was counted with a hemocy-
tometer under a microscope. For this purpose, 50 µL
of the peritoneal cell suspension (5×105 cellsmL)
was smeared on a microscope slide after centrifuga-
tion. A differential cell count was carried out under a
microscope after fixation and staining with May-
Grunwald Giemsa dye.25
An experiment was carried out using the above
four experimental mouse strains . As shown in Ta-
ble 4,50 the results were similar to those of ACA in
which the C57BL6 strain showed a markedly high
value : about one and a half times higher than that of
the BALBc strain. On the other hand, the value of
the C3HHeN strain was less than half that of the
BALBc strain while the value of the C3HHeJ strain
was equivalent to that of the BALBc strain.
Although ACA and the experimental system of lo-
cal accumulation of eosinophils have completely dif-
ferent response pathways, the C57BL6 strain, which
is considered to be Th1-dominant, responded more
strongly than the BALBc strain, which is considered
to be Th2-dominant. These results suggested that the
response of allergy models was likely unrelated to
Th1Th2 balance. Furthermore, this obvious differ-
ence between the C3HHeN and the C3HHeJ
strains indicated that eosinophils might be influenced
by TLR4
BALBc, C57BL6, C3HHeN, and the C3HHeJ
strains showed 66.8%, 95.4%, 60.1%, and 70.0%, respec-
tively, to 100% for a control, as in ACA, in the experi-
mental system of accumulation of eosinophils. Sup-
pression by LFK was observed in the strains other
than the C57BL6 strain.
CONCLUDING COMMENTS
Genetic differences among different individuals may
not necessarily be equal to differences among differ-
ent lines of mice. However, it is at least quite interest-
ing that the effects of LFK on allergic responses vary
in intensity in different genetic backgrounds . The
genes related to the differences are not well known at
present. However, if TLRs alone are focused on, the
involvement of TLR 2, 4, 5, and 6 is inferred from dif-
ferences in responsiveness between the BALBc and
the C57BL6 strains ; TLR4 is not inferred to be in-
volved on the basis of comparison between the C3H
HeN and C3HHeJ strains ; and TLR5 is not inferred
to be involved from the fact that LFK is a non-
flagellate bacterium . It is necessary to confirm
whether these inferences are true by using TLR-
knockout mice and, furthermore, studying the corre-
lation between expression of TLRs and the effect of
LFK on allergic symptoms in humans in the future
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